REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/04/2026
Voltar para busca
Dado oficial do USPTO
PHARMATHEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000086855200Classe
5, 35, 41, 42, 44
Pedido
86855200
Registro
5174237
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
05/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 41, 42, 44
Data de depósito
21/12/2015
Data de registro
04/04/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/11/2024
Última transação
05/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Marousi, Attica, GR
Examinador
DOMBROW, COLLEEN M
Localização atual
Historical data usage
Descrição da marca
The mark consists of a stylized cross with rounded edges in red color and the stylized word "Pharmathen" in green color to the right of the design.
Titulares e representantes
Titulares
Pharmathen S.A.
Pharmathen S.A.
Representantes
Bradford C. Craig BLANK ROME LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Generic pharmaceutical preparation for the treatment of gout; Generic pharmaceutical preparations acting on the central nervous system; Generic pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Generic pharmaceutical preparations for animal skincare; Generic pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Generic pharmaceutical preparations for ocular or intraocular surgery; Generic pharmaceutical preparations for the treatment of heart rhythm disorders; Generic pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Generic pharmaceutical preparations for the treatment of infectious diseases; Generic pharmaceutical preparations for treating allergic rhinitis and asthma; Generic pharmaceutical preparations for treating diabetes; Generic pharmaceutical preparations for treating skin disorders; Generic pharmaceutical preparations for use in chemotherapy; Generic pharmaceutical preparations for use in dermatology; Generic pharmaceutical preparations for use in urology; Generic pharmaceutical preparations for wounds; Generic pharmaceutical preparationsanticoagulants; Generic pharmaceutical preparationsantidepressants; Generic pharmaceutical preparationsappetite suppressants. Generic pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Generic pharmaceutical preparationsa drug delivery system comprising polymerbased oral tablets for the continuous release of a wide variety of therapeutic agents; Preparations for destroying parasites; Preparations for destroying vermin; Sanitary preparations for medical use; Self adhesive dressings; Veterinary preparationspain relief medication
Classe 35
Providing advertisingmarketing and promotional services for the generic pharmaceutical and medical industry. Providing advertisingmarketing and promotional services for the generic pharmaceuticals and medical products of others; Providing information on the topic of promoting patientphysician and employee satisfaction via a global computer network
Classe 41
Education servicesmentoring in the field of generic pharmaceuticalsdiagnostic preparationsveterinary preparationsproprietary medicinestoiletries and cosmetics; Educational servicesproviding classesseminars and workshops in the fields of generic pharmaceuticalsdiagnostic preparationsveterinary preparationsproprietary medicinestoiletries and cosmetic industries; Providing continuing medical education courses
Classe 42
Medical and scientific research services in the field of cancer treatment and diagnosis; Generic pharmaceutical drug development services; generic Pharmaceutical research services; Professional consulting services and advice about agricultural chemistry; Scientific consulting and research services relating to foods and dietary supplements; Technical consultancy in relation to research services relating to foods and dietary supplements; Scientific investigations for medical purposes in the field of generic pharmaceuticals; Scientific research in the field of generic pharmaceuticals; Scientific research and development in the field of generic pharmaceuticals
Classe 44
Medical services; Providing health care information by telephone; Providing health care information by telephone and the Internet; Providing health information; Providing information about beauty; Providing medical informationconsultancy and advisory services in the field of generic pharmaceuticals; Veterinary services
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
19/11/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19/11/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
22/03/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
22/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
22/03/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/01/2017
PUBO
PUBLISHED FOR OPPOSITION
17/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/12/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2016
ALIE
ASSIGNED TO LIE
10/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/10/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/07/2016
GNRT
NON-FINAL ACTION E-MAILED
26/07/2016
CNRT
NON-FINAL ACTION WRITTEN
26/07/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2016
GNRT
NON-FINAL ACTION E-MAILED
08/04/2016
CNRT
NON-FINAL ACTION WRITTEN
08/04/2016
DOCK
ASSIGNED TO EXAMINER
08/04/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
31/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2015
NWAP
NEW APPLICATION ENTERED
28/12/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARMATHEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.